feed,title,long_url,short_url
Benzinga,Incyte's Parsaclisib Application Under FDA Review For 3 Types Of Non-Hodgkin Lymphomas,https://benzinga.com/general/biotech/21/11/23790813/incytes-parsaclisib-application-under-fda-review-for-3-types-of-non-hodgkin-lymphomas,https://j.mp/2ZFnfba
Benzinga,Cocrystal Pharma Files To Start Human Trial For Protease Inhibitor In COVID-19,https://benzinga.com/general/biotech/21/11/23789586/cocrystal-pharma-files-to-start-human-trial-for-protease-inhibitor-in-covid-19,https://j.mp/3CBeBJp
Benzinga,Cabaletta Posts Cell Therapy Data From Third Cohort Of Autoimmune Skin Disorder Trial,https://benzinga.com/general/biotech/21/11/23788727/cabaletta-posts-cell-therapy-data-from-third-cohort-of-autoimmune-skin-disorder-trial,https://j.mp/3GDPjgh
